Drug:
Reaction: PRODUCT USE ISSUE
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26503644 |
CA |
59 | 1 |
Endocarditis, Immunodeficiency, White blood cell count decreased, Product use issue, |
||||
ADALIMUMAB-BWWD, |
||||
| 402 | 26503647 |
EU |
90 | 2 |
Agranulocytosis, Product use issue, |
||||
ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FUROSEMIDE, PANTOPRAZOLE, RAMIPRIL, PREDNISONE, APIXABAN, FENTANYL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIGOXIN, |
||||
| 403 | 26503652 |
EU |
14 | |
Intentional overdose, Product use issue, Suicide attempt, Abdominal pain, Nausea, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 404 | 26503653 |
EU |
16 | |
Intentional overdose, Abdominal pain, Product use issue, Nausea, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 405 | 26503654 |
EU |
13 | |
Intentional overdose, Nausea, Product use issue, Vomiting, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 406 | 26503655 |
EU |
15 | |
Intentional overdose, Product use issue, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 407 | 26503745 |
US |
58 | 2 |
Drug ineffective, Application site pain, Product use issue, Application site erythema, Wrong technique in product usage process, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE, |
||||
| 408 | 26503829 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 409 | 26503892 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 410 | 26504006 |
US |
||
Oxygen saturation decreased, Fatigue, Product use issue, Apathy, Anxiety, Asthenia, Dyspnoea, Dizziness, Hypersensitivity, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CARVEDILOL, IBANDRONATE SODIUM, POTASSIUM CHLORIDE, ALLOPURINOL, AZELASTINE HYDROCHLORIDE, AZELASTINE, LOSARTAN POTASSIUM, LOSARTAN, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OXYGEN, 0XYGEN, CHLORTHALIDONE, AMLODIPINE BESYLATE, ERGOCALCIFEROL, |
||||
| 411 | 26504009 |
US |
||
Nervousness, Fall, Lip injury, Dyspnoea exertional, Decreased appetite, Sinusitis, Feeling abnormal, Cough, Dyspnoea, Nausea, Dizziness, Diarrhoea, Product use issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, FUROSEMIDE, FOLIC ACID, PREDNISONE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PERFLUOROHEXYLOCTANE, TOCILIZUMAB, OXYGEN, 0XYGEN, IRON, LEVOTHYROXINE SODIUM, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, BUPROPION HYDROCHLORIDE, PREDNISONE, |
||||
| 412 | 26504148 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 413 | 26504168 |
US |
39 | |
Drug dose omission by device, Product use issue, Device defective, |
||||
ADALIMUMAB-AQVH, |
||||
| 414 | 26504418 |
US |
68 | 2 |
Illness, Expired product administered, Product storage error, Product use issue, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 415 | 26504423 |
US |
||
Product use issue, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 416 | 26504490 |
23 | ||
Seizure, Epilepsy, Musculoskeletal stiffness, Sleep deficit, Headache, Therapy interrupted, Product dispensing issue, Product use issue, |
||||
LACOSAMIDE, LACOSAMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, VALPROIC ACID, VALPROIC ACID, CLOBAZAM, CLOBAZAM, |
||||
| 417 | 26504575 |
CA |
25 | 2 |
Infection, Clostridium difficile infection, Opportunistic infection, Immunodeficiency, Nasopharyngitis, Pain, Crying, Product use issue, |
||||
ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, HYDROXYCHLOROQUINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASCORBIC ACID, |
||||
| 418 | 26504742 |
US |
70 | |
Pain, Product use issue, Product availability issue, |
||||
| 419 | 26504876 |
US |
1 | |
Chronic kidney disease, Craniocerebral injury, Product use issue, |
||||
| 420 | 26505016 |
EU |
15 | |
Intentional overdose, Vomiting, Product use issue, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 421 | 26505023 |
CA |
13 | 2 |
Sepsis, Pancreatitis, Pharyngeal swelling, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, LEVOTHYROXINE SODIUM, SPIRONOLACTONE, PREDNISONE, MAGNESIUM, LETROZOLE, LETROZOLE TABLETS, HYDROCHLOROTHIAZIDE, FOLIC ACID, CALCIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 422 | 26505051 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN, ROSUVASTATIN CALCIUM, USTEKINUMAB, LEVOTHYROXINE SODIUM, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 423 | 26505058 |
US |
71 | 1 |
Mood swings, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 424 | 26505138 |
EU |
15 | 1 |
Suicide attempt, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 425 | 26505146 |
EU |
16 | 2 |
Suicide attempt, Abdominal pain, Nausea, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 426 | 26505148 |
US |
2 | |
Colitis, Product dose omission issue, Product use issue, |
||||
DEURUXOLITINIB PHOSPHATE, |
||||
| 427 | 26505367 |
CA |
72 | 2 |
Cardiac failure, Discoloured vomit, Fall, Hallucination, auditory, Internal haemorrhage, Respiratory arrest, Tremor, Underdose, Drug ineffective, Product use issue, |
||||
OLANZAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, LORAZEPAM, DABIGATRAN ETEXILATE MESYLATE, ERGOCALCIFEROL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, NIACIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LEVOTHYROXINE SODIUM, |
||||
| 428 | 26505529 |
US |
46 | 1 |
Overdose, Product use issue, Extra dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 429 | 26505612 |
BR |
64 | 2 |
Gait disturbance, Visual impairment, Product use issue, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 430 | 26505679 |
US |
1 | |
Dementia Alzheimer^s type, Blood glucose increased, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 431 | 26505881 |
US |
||
Vulvovaginal burning sensation, Product use issue, |
||||
ESTRADIOL, PRIMIDONE, LORAZEPAM, PAROXETINE HYDROCHLORIDE, OMALIZUMAB, |
||||
| 432 | 26506037 |
US |
60 | |
Extra dose administered, Incorrect dose administered, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 433 | 26506237 |
CA |
55 | 2 |
Atrial fibrillation, Back pain, Bladder disorder, Blood pressure increased, Blood pressure systolic increased, Bone disorder, Bone pain, Cardiac failure, Change of bowel habit, Contusion, Cough, Diabetes mellitus, Duodenal ulcer, Dysuria, Exostosis, Feeling abnormal, Frustration tolerance decreased, Full blood count decreased, Furuncle, Gait disturbance, Gallbladder disorder, Haemoglobin decreased, Haemorrhage, Helicobacter infection, Hyperhidrosis, Hypoaesthesia, Intestinal haemorrhage, Joint swelling, Limb discomfort, Lung neoplasm malignant, Mass, Muscular weakness, Musculoskeletal discomfort, Musculoskeletal pain, Pain in extremity, Peripheral coldness, Peripheral swelling, Polyp, Postoperative wound infection, Proctalgia, Anorectal polyp, Stress, Sensitisation, Arthritis, Arthralgia, Malaise, Urinary incontinence, Urinary tract infection, Urine abnormality, Urine odour abnormal, Weight decreased, Pyrexia, Pneumonia, COVID-19, Pain, Feeling cold, Illness, Product use issue, Needle issue, Underdose, Fatigue, Blood glucose decreased, Heart rate decreased, Abdominal discomfort, Abdominal pain upper, Dizziness, Dyspnoea, Decreased appetite, Dehydration, Jaundice, Thyroid disorder, Headache, Injection site mass, Injection site bruising, Injection site discomfort, Injection site pain, Nausea, Asthenia, Blood pressure abnormal, Diarrhoea, Eating disorder, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, RAMIPRIL, RAMIPRIL, RAMIPRIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, INDAPAMIDE, INDAPAMIDE, ATENOLOL, ATENOLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), PREDNISONE, PREDNISONE, PEGVISOMANT, PEGVISOMANT, TEMAZEPAM, TEMAZEPAM, RIVAROXABAN, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, GLYCOPYRROLATE, |
||||
| 434 | 26506287 |
EU |
14 | 2 |
Suicide attempt, Intentional overdose, Product use issue, Abdominal pain, Nausea, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 435 | 26506383 |
US |
74 | 2 |
Product use issue, Rash, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 436 | 26506512 |
US |
78 | 1 |
Hospitalisation, Product use issue, |
||||
RIFAXIMIN, |
||||
| 437 | 26506756 |
EU |
13 | 2 |
Suicide attempt, Abdominal pain, Nausea, Vomiting, Headache, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 438 | 26506768 |
US |
35 | 2 |
Death, Off label use, Product use issue, |
||||
TUCATINIB, TUCATINIB, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, FLUCONAZOLE, |
||||
| 439 | 26506779 |
US |
||
Product dose omission issue, Product use issue, |
||||
LENALIDOMIDE, |
||||
| 440 | 26506860 |
EU |
13 | 2 |
Suicide attempt, Nausea, Vomiting, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 441 | 26507034 |
US |
70 | 2 |
Vaginal disorder, Nausea, Vomiting, Product use issue, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 442 | 26507102 |
20 | ||
Condition aggravated, Product use issue, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, LIDOCAINE PATCH 5%, LIDOCAINE, |
||||
| 443 | 26507114 |
US |
2 | |
Constipation, Metabolic disorder, Weight increased, Pain, Food craving, Blood pressure increased, Blood glucose increased, Anal incontinence, General physical health deterioration, Asthenia, Hyperphagia, Feeling abnormal, Dyspepsia, Gastric dilatation, Abdominal distension, Fluid retention, Drug ineffective, Product use issue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ESCITALOPRAM, |
||||
| 444 | 26507262 |
US |
58 | |
Respiratory tract infection, Pneumonia, Illness, Rib fracture, Product use issue, |
||||
| 445 | 26507402 |
US |
1 | |
Renal impairment, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 446 | 26507462 |
US |
2 | |
Product use issue, Syncope, |
||||
DAPAGLIFLOZIN, |
||||
| 447 | 26507524 |
US |
51 | 2 |
Recurrent cancer, Incorrect dosage administered, Product dose omission issue, Product use issue, |
||||
OLAPARIB, |
||||
| 448 | 26497984 |
CA |
2 | |
Pain, Headache, Joint swelling, Intentional product misuse, Infusion related reaction, Hypertension, Hypersensitivity, Food allergy, Immunodeficiency, Product use issue, Prescribed overdose, Maternal exposure during pregnancy, Hyperhidrosis, Hepatic enzyme increased, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, ABACAVIR SULFATE, CYCLOBENZAPRINE, BUPROPION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, TOCILIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PROGESTERONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 449 | 26498263 |
US |
2 | |
Viral mutation identified, Exposure during pregnancy, Product use in unapproved therapeutic environment, Product use issue, |
||||
CABOTEGRAVIR AND RILPIVIRINE, DOLUTEGRAVIR SODIUM, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 450 | 26498429 |
US |
12 | 1 |
Haemorrhage, Product use issue, |
||||
| 451 | 26498442 |
US |
73 | 2 |
Diabetes mellitus, Gait disturbance, Depressed mood, Product use issue, Product dose omission issue, |
||||
INTERFERON BETA-1A, |
||||
| 452 | 26498516 |
JP |
77 | 2 |
Tracheal haemorrhage, Pneumonia, Platelet count decreased, Product use issue, |
||||
ZOLBETUXIMAB, EDOXABAN TOSYLATE, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, VONOPRAZAN FUMARATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, SPIRONOLACTONE, FUROSEMIDE, |
||||
| 453 | 26498650 |
US |
2 | |
Treatment noncompliance, Product dose omission issue, Malaise, Product dispensing error, Product use issue, Product package associated injury, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 454 | 26498930 |
EU |
13 | |
Intentional overdose, Abdominal pain, Nausea, Vomiting, Headache, Product use issue, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 455 | 26498947 |
US |
21 | 2 |
Product use issue, |
||||
VIMSELTINIB, VIMSELTINIB, |
||||
| 456 | 26499230 |
US |
36 | 2 |
Product use issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 457 | 26499266 |
EU |
2 | |
Malignant neoplasm progression, Product use issue, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 458 | 26499330 |
US |
73 | 1 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 459 | 26499548 |
EU |
75 | 1 |
Malignant neoplasm progression, Erythema multiforme, Product use issue, Therapy partial responder, Alopecia, Asthenia, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 460 | 26499602 |
US |
91 | 1 |
Product use issue, Muscular weakness, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 461 | 26499617 |
68 | ||
Seizure, Product use issue, Therapy interrupted, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, |
||||
| 462 | 26499631 |
US |
||
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 463 | 26499675 |
US |
||
Hospitalisation, Product use issue, |
||||
BOSENTAN, |
||||
| 464 | 26499750 |
EU |
16 | |
Intentional overdose, Abdominal pain, Product use issue, Headache, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 465 | 26499813 |
CA |
47 | 2 |
Abdominal discomfort, Abdominal pain upper, Arthralgia, Cardiac failure, Cardiac failure congestive, Contraindicated product administered, Cough, Diarrhoea, Drug hypersensitivity, Drug intolerance, Dyspnoea, Gastrointestinal disorder, Headache, Hepatic enzyme increased, Hepatic steatosis, Hypersensitivity, Hypertension, Liver disorder, Loss of employment, Malaise, Nausea, Off label use, Pain, Product use issue, Rash, Therapeutic product effect decreased, |
||||
RITUXIMAB, RITUXIMAB, LEUCOVORIN CALCIUM, CIPROFLOXACIN HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, GOLD, ADALIMUMAB, ADALIMUMAB, LEUCOVORIN CALCIUM, PERINDOPRIL ERBUMINE, PREDNISONE, PREDNISONE, PREDNISONE, RANITIDINE, RANITIDINE HYDROCHLORIDE, PATIROMER, |
||||
| 466 | 26500211 |
US |
43 | 2 |
Pyrexia, Catheter site erythema, Catheter site warmth, Product use issue, |
||||
ABALOPARATIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ADALIMUMAB-ADAZ, ADALIMUMAB, |
||||
| 467 | 26500559 |
US |
2 | |
Hallucination, Delusion, Abnormal behaviour, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 468 | 26500698 |
6 | 1 | |
Hereditary angioedema, Product use issue, |
||||
ALBUTEROL SULFATE, BUDESONIDE, |
||||
| 469 | 26500714 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 470 | 26500724 |
US |
72 | 1 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 471 | 26500763 |
1 | ||
Intentional dose omission, Product use issue, |
||||
ENTECAVIR, ENTECAVIR ANHYDROUS, ACYCLOVIR, ALBUTEROL SULFATE, AMLODIPINE, BENZONATATE, CETIRIZINE HCL, CETIRIZINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 472 | 26501135 |
JP |
41 | 2 |
Cardio-respiratory arrest, Phaeochromocytoma crisis, Hypoxic-ischaemic encephalopathy, Respiratory failure, Hypoxia, Pulmonary oedema, Stress cardiomyopathy, Product use issue, Product use in unapproved indication, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, CARVEDILOL, CARVEDILOL, AMLODIPINE, |
||||
| 473 | 26501460 |
US |
||
Product storage error, Product use issue, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 474 | 26501616 |
US |
||
Liver transplant, Pulmonary congestion, Gastroenteritis viral, Abdominal pain upper, Abdominal discomfort, Malaise, Sleep disorder, Somnolence, Sinus congestion, COVID-19, Nausea, Headache, Cough, Diarrhoea, Fatigue, Product use issue, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TIRZEPATIDE, MACITENTAN, CARVEDILOL, FUROSEMIDE, VITAMIN C, OXYMETAZOLINE HYDROCHLORIDE, OXYMETAZOLINE HYDROCHLORIDE., SPIRONOLACTONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TADALAFIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, GUAIFENESIN, ALBUTEROL SULFATE, PANCRELIPASE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 475 | 26501900 |
AU |
2 | |
Haemorrhage, Product use issue, Maternal exposure during pregnancy, |
||||
SEMAGLUTIDE, |
||||
| 476 | 26501936 |
CA |
44 | 2 |
Maternal exposure during pregnancy, Pemphigus, Pericarditis, Peripheral swelling, Rheumatoid arthritis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Synovitis, Systemic lupus erythematosus, Wound, Weight increased, Pruritus, Pyrexia, Rash, Sinusitis, Swelling, Treatment failure, Therapeutic product effect decreased, Product use issue, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Duodenal ulcer perforation, Intentional product use issue, Medication error, Off label use, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PREDNISOLONE ACETATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CELECOXIB, CELECOXIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GOLIMUMAB, VITAMIN C, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, NAPROXEN, NAPROXEN SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE SODIUM PHOSPHATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, SULFASALAZINE, SULFASALAZINE, LORAZEPAM, CAFFEINE, CYANOCOBALAMIN, ERGOCALCIFEROL, LISINOPRIL, LORAZEPAM, MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, |
||||
| 477 | 26502116 |
EU |
52 | 2 |
Postmenopausal haemorrhage, Insomnia, Food craving, Headache, Psoriasis, Calcium deficiency, Magnesium deficiency, Iron deficiency, Limb discomfort, Fluid retention, Therapeutic product effect decreased, Product use issue, Underdose, Wrong technique in product usage process, |
||||
PROGESTERONE, PROGESTERONE, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRIOL0.2%, ESTRIOL, |
||||
| 478 | 26502221 |
US |
17 | 2 |
Product use issue, Drug ineffective, Petit mal epilepsy, |
||||
LEVACETYLLEUCINE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 479 | 26502624 |
JP |
13 | 2 |
Graves^ disease, Cardiac failure, Hyperthyroidism, Product use issue, Off label use, |
||||
EPOPROSTENOL SODIUM, |
||||
| 480 | 26502673 |
US |
1 | |
Drug dose omission by device, Device leakage, Product use issue, |
||||
SECUKINUMAB, EMPAGLIFLOZIN, |
||||
| 481 | 26497429 |
US |
66 | 2 |
Pruritus, Rash, Product dose omission issue, Product use issue, |
||||
REMIBRUTINIB, REMIBRUTINIB, |
||||
| 482 | 26497486 |
IN |
16 | 1 |
Malignant neoplasm progression, Thrombocytopenia, Product use issue, Off label use, Underdose, Product use issue, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, |
||||
| 483 | 26497584 |
US |
2 | |
Feeling jittery, Anxiety, Product dose omission issue, Product use issue, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 484 | 26497726 |
US |
||
Product use issue, |
||||
ACORAMIDIS HYDROCHLORIDE, |
||||
| 485 | 26499910 |
83 | 1 | |
Withdrawal syndrome, Rash, Pruritus, Peripheral swelling, Peripheral swelling, Product use issue, |
||||
ALLOPURINOL, AMLODIPINE, ROSUVASTATIN, |
||||
| 486 | 26496706 |
EU |
1 | |
Urinary tract infection, Product use issue, Device occlusion, Somnolence, |
||||
| 487 | 26496877 |
US |
1 | |
Diabetes mellitus, White blood cell count increased, Cough, Product use issue, Product dose omission issue, |
||||
ACALABRUTINIB, |
||||
| 488 | 26496982 |
US |
||
Drug withdrawal syndrome, Product use issue, |
||||
ZOLPIDEM TARTRATE, |
||||
| 489 | 26497021 |
US |
2 | |
Product use issue, Product distribution issue, |
||||
| 490 | 26492029 |
US |
90 | 1 |
Fall, Product use in unapproved indication, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 491 | 26492048 |
US |
||
Product use issue, Therapy non-responder, |
||||
OXYCODONE, |
||||
| 492 | 26492357 |
CN |
70 | 2 |
White blood cell count decreased, Malignant neoplasm progression, Myelosuppression, Neutrophil count abnormal, Red blood cell count abnormal, Haemoglobin abnormal, Product use issue, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 493 | 26492442 |
EU |
74 | 1 |
Gynaecomastia, Product use issue, |
||||
TRIPTORELIN, |
||||
| 494 | 26492445 |
CA |
15 | 2 |
Product prescribing issue, Drug ineffective, Product use issue, |
||||
GABAPENTIN, CELECOXIB, CLONIDINE, MAGNESIUM OXIDE, |
||||
| 495 | 26492458 |
US |
2 | |
Incorrect dose administered, Intentional product use issue, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 496 | 26492664 |
US |
55 | 2 |
Colitis, Loss of consciousness, Diarrhoea, Dizziness, Migraine, Hypophagia, Dry skin, Constipation, Blood pressure increased, Therapy interrupted, Product use issue, |
||||
METHYLNALTREXONE BROMIDE, TRETINOIN, EFINACONAZOLE, LULICONAZOLE, TAZAROTENE, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE, FLUCYTOSINE, METRONIDAZOLE, PLECANATIDE, RIFAXIMIN, TRETINOIN, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, CLINDAMYCIN, BUPROPION HYDROBROMIDE, LIFITEGRAST, PERFLUOROHEXYLOCTANE, LOTEPREDNOL ETABONATE AND TOBRAMYCIN, ALPRAZOLAM, BESIFLOXACIN, LOTEPREDNOL ETABONATE, LOTEPREDNOL ETABONATE, TRETINOIN, |
||||
| 497 | 26492687 |
US |
69 | 1 |
Lethargy, Activities of daily living decreased, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 498 | 26492973 |
US |
2 | |
Product quality issue, Product use issue, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 499 | 26493137 |
CA |
60 | 2 |
Hypertension, Blood cholesterol increased, Heart rate increased, Diabetes mellitus, Headache, Nausea, Malaise, White coat hypertension, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AMLODIPINE, |
||||
| 500 | 26493212 |
CA |
44 | |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Asthma, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Condition aggravated, Confusional state, Death neonatal, Diarrhoea, Discomfort, Dizziness, Adverse event, Adverse drug reaction, Contraindicated product administered, Product use issue, Exposure during pregnancy, Intentional product use issue, Live birth, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Off label use, Pregnancy, Prescribed overdose, Intentional product use issue, Intentional product use issue, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, USTEKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28